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Real-Time Patch-Cram Detection of Intracellular
cGMP Reveals Long-Term Suppression of Responses
to NO and Muscarinic Agonists
the levels of cyclic nucleotides in cells. Biochemical
techniques, such as radio- or enzyme-immunoassay,
allow for quantitation of total cellular cAMP or cGMP
but do not provide information about the concentration
of free cytoplasmic cyclic nucleotides. For cAMP, a fluo-
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rescence detection method has been developed using
ªFlCRhR,º which consists of fluorescein conjugated toSummary
the catalytic (C) subunit of cAMP-dependent protein
kinase (PKA), and rhodamine conjugated to the regula-Cyclic GMP (cGMP) is a crucial intracellular messen-
tory (R) subunit (Adams et al., 1991). Fluorescence en-ger in neuronal, muscle, and endocrine cells. The intra-
ergy transfer between the two fluorophores in the holo-cellular concentration of cGMP is regulated by various
enzyme (R2C2) is eliminated when the R and C subunitsneurotransmitters, including acetylcholine (ACh) and
dissociate upon cAMP binding, and this can be detectednitric oxide (NO). While much is known about the bio-
spectrophotometrically. The FlCRhR method has pro-chemical steps leading to cGMP synthesis, little is
vided some information, albeit with limited temporal res-known about cGMP kinetics in intact cells. Here, we
olution, about the concentration of free cAMP in cells.use ªpatch-cramming,º in which an excised, inside-
However, there are presently no fluorescent indicatorsout membrane patch containing cyclic nucleotide±
for cGMP or indeed any other methods for measuringgated ion channels is used as a biosensor, to obtain
cGMP in living cells.the first real-time measurements of cGMP in intact
Here, we report the first real-time detection of cGMPcells. Patch-cramming experiments on neuroblastoma
in living cells. Our method utilizes a different cyclic nu-cells show that both muscarinic agonists and NO rap-
cleotide effector protein: cyclic nucleotide±gated (CNG)idly elevate cGMP. NO elicits cGMP responses repeat-
ion channels, which are directly activated by the bindingedly without decrement, whereas responses to mus-
of cGMP or cAMP. In particular, we use an exogenouslycarinic agonists exhibit a profound and prolonged
expressed CNG channel that is engineered to be espe-desensitization. Remarkably, muscarinic agonists also
cially sensitive and selective for cGMP (Goulding et al.,cause long-term (.30 min) suppression (LTS) of cGMP
1994). This channel is used as a detector in ªpatch-responses elicited by NO. Biochemical measurements
crammingº experiments (Kramer, 1990), in which an ex-
reveal that rat sympathetic neurons also exhibit LTS
cised, inside-out membrane patch containing these
of cGMP, suggesting that LTS is a widespread mecha-
channels is ªcrammedº into a recipient cell, bringing the
nism that may contribute to synaptic plasticity.
intracellular cGMP binding sites into contact with the
cytoplasm. Hence, the activity of these channels reflects
Introduction the concentration of free cGMP in the recipient cell.
Since the response of these channels is rapid and does
Cyclic GMP (cGMP) is a crucial intracellular messenger not desensitize, activation of the channels is a high-
involved in many physiological processes, including fidelity indicator of cGMP.
phototransduction (Yau and Baylor, 1989; Pugh and In this study, we use the patch-cramming method to
Lamb, 1990), regulation of smooth muscle contraction monitor the effect of muscarinic agonists and NO on
(McDonald and Murad, 1996), and neuronal function cGMP in single differentiated neuroblastoma cells. Mus-
(Jaffrey and Snyder, 1995). cGMP is particularly impor- carinic receptors are important for mediating the slow
tant in mediating responses to transmitters such as ace- synaptic effects of ACh in sympathetic neurons (Hashi-
tylcholine (ACh), bradykinin, and natriuretic peptides guchi et al., 1982; Kobayashi et al., 1992), which share
(Burgess et al., 1989; Goy, 1991; Kobayashi et al., 1992). many physiological and biochemical properties with
In addition, most of the effects of NO have been attrib- neuroblastoma cells (Kimhi et al., 1976). Activation of
uted to activation of soluble guanylate cyclase and pro- muscarinic receptors leads to G protein±mediated pro-
duction of cGMP (Schmidt et al., 1993a). In both the duction of IP3 (Briggs et al., 1985), which triggers Ca21
hippocampus and the cerebellum, there is evidence that release from internal stores (Thompson et al., 1995). In
cGMP is an important intracellular messenger involved turn, the elevated Ca21 activates NO synthase, resulting
in the initiation of long-term potentiation (LTP) and long- in production of NO (Forstermann et al., 1990; Thompson
term depression (LTD) of synaptic transmission (Hawkins et al., 1995). NO activates soluble guanylate cyclase,
et al., 1994; Gage et al., 1997; Lev-Ram et al., 1997). leading to production of cGMP (Ignarro, 1990; Hu and
While there is a growing awareness about the physiolog- el-Fakahany, 1993). The muscarinic-induced elevation
ical importance of cGMP and much is known about the of cGMP plays a role in several physiological functions,
biochemistry of cGMP signaling cascades, very little is including refilling of intracellular Ca21 stores (Harrington
known about the intracellular dynamics of cGMP in living and Thompson, 1996) and modulation of slow synaptic
cells. potentials (Kobayashi, 1982; Briggs, 1992).
Several methods have been developed for measuring Muscarinic receptors also initiate other signaling cas-
cades involving different downstream events, including
direct G protein modulation of ion channels (i.e., M chan-* To whom correspondence should be addressed (e-mail: rkramer
@chroma.med.miami.edu). nels; Caulfield et al., 1994) and activation of protein
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Figure 1. Schematic Diagram of the Patch-Cramming Method for Detection of cGMP
(1) A cGMP detector patch is obtained from an oocyte expressing CNG channels.
(2) The detector patch is calibrated with various concentrations of cGMP.
(3) The detector patch is inserted into a recipient cell to monitor intracellular cGMP while applying neurotransmitters or other agonists onto
the cell. The recipient cell can also be voltage clamped with nystatin (N) perforated patch.
kinase C (Kobayashi et al., 1992; Brown et al., 1997). In mM), and it is activated by cAMP only at much higher
concentrations (.100 mM) (Figure 2A). Like most otheraddition, there are feedback mechanisms that regulate
CNG channels, RONS2 has voltage-insensitive gatingmuscarinic signaling cascades; for example, elevated
and exhibits no desensitization, even with continuousCa21 activates Ca21/calmodulin-dependent phosphodi-
cGMP application for many minutes. In addition, Ca21/esterase (PDE), which may lower levels of cGMP (Beavo,
calmodulin, which can modulate the sensitivity of certain1995). This complex ªspaghetti networkº of intracellular
CNG channels (Molday, 1996), and NO, which can di-signals makes it difficult to assess the roles of individual
rectly activate the rat olfactory CNG channel (Broilletbiochemical processes in determining muscarinic ef-
and Firestein, 1996), have no direct effect on RONS2fects. The ability to detect cGMP adds a new reference
and do not modulate its sensitivity to cGMP (Figure 2B).point for monitoring this particular signaling cascade,
The cyclic nucleotide sensitivity of CNG channels canrevealing new insights and providing a more compre-
be modulated by phosphorylation (Gordon et al., 1992;hensive view of cell signaling.
Molokanova et al., 1997; Muller et al., 1998). Rod CNG
channels expressed in oocytes exhibit a gradual in-Results
crease in cGMP sensitivity (decrease in K1/2) after patch
excision, owing to dephosphorylation by membrane-The Patch-Cram Method
associated tyrosine phosphatases (Molokanova et al.,Figure 1 shows a diagram of the patch-cram method
1997). This process can be partially reversed by adding
for monitoring cGMP. First, a glass patch pipette is used
0.1±1 mM ATP, suggesting that membrane-associated
to obtain a cGMP detector patch, which is an inside-
tyrosine kinases can decrease cGMP sensitivity by
out, excised patch from a Xenopus oocyte expressing phosphorylating either the channel or some closely as-
a high density of CNG channels. Second, to calibrate sociated accessory protein. We have found that similar
the patch, various concentrations of cGMP are applied changes in cGMP sensitivity occur in RONS2 channels
to elicit CNG current and generate a dose±response expressed in Xenopus oocytes. However, the effects
curve. Next, a nystatin-perforated patch is obtained on are very small (e.g., ATP changes the K1/2 for cGMP from
the recipient cell so that the membrane potential can 3.5 mM to 4.0 mM over 10 min) and the sensitivity remains
be voltage clamped and the leak current can be moni- stable when the channels are kept in the continuous
tored, to give an indication of when the cell membrane presence of ATP, as would be the case in patch-cram-
is breached with the detector patch pipette. Finally, after ming experiments once the detector patch is inserted
the detector patch pipette is inserted (ªcrammedº) into into the recipient cell. Furthermore, calibrations of the
the cell, neurotransmitters or other pharmacological detector patch before and after patch cramming re-
agents are perfused onto the cell to determine their vealed no significant change in the cGMP sensitivity
effects on intracellular cGMP. (see Figures 3, 6, and 7).
To accurately measure cGMP, the detector patch To maximize expression of CNG channels and opti-
should be sufficiently sensitive and selective for cGMP. mize signal resolution, oocytes were injected with a
We used a chimeric CNG channel, consisting of portions large amount of CNG channel cRNA (10±15 ng/oocyte),
of the bovine rod photoreceptor channel a subunit resulting in excised patches containing up to 1500
(Kaupp et al., 1989), which is highly selective for cGMP, channels. This channel density allows cGMP to be mea-
and portions of the rat olfactory CNG channel a subunit sured with high resolution at concentrations as low as
(Dhallan et al., 1990), which is highly sensitive to cyclic 0.5 mM (Figure 2C), even though this concentration of
nucleotides. The resulting chimeric channel (RONS2; cGMP activates ,1% of the total conductance. Detector
Goulding et al., 1994) is both highly selective and sensi- patches with fewer than 500 channels could not resolve
tive for cGMP. Indeed, it is ideal for use as a biosensor ,1 mM cGMP and were not used for patch cramming.
for cGMP because it is most sensitive in the range of The response of detector patches to cGMP was cali-
brated by determining the conductance with repeatedcGMP concentrations expected in cells (e.g., 0.1±10
Monitoring cGMP in Living Neurons
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Figure 2. The cGMP Detector Patch Is Highly Sensitive and Selective for cGMP
(A) Dose±response curves of RONS2 to cGMP and cAMP. Continuous lines represent fits to the Hill equation.
(B) The bars represent the concentration of cGMP required to reach half-maximal activation (K1/2) with cGMP alone or in the presence of
NOR-4, an NO donor, or Ca21/calmodulin. Neither agent significantly effects the sensitivity (K1/2) of the cGMP detector patch. Application of
NOR-4 or Ca21/calmodulin alone did not produce a detector patch response. In addition, the following agents used in patch-cramming
experiments had no effect on the detector patch or its sensitivity to cGMP: ODQ, IBMX, oxo-M, 7-NI, and nystatin (data not shown).
(C) cGMP detector patch currents showing that ,1 mM cGMP, exogenously applied, can be detected with high temporal resolution. The patch
was held at 275 mV, and 350 ms duration pulses to 0 mV were applied every 500 ms.
voltage pulses while applying various concentrations of (oxo-M) onto the neuroblastoma cell induced an in-
crease in both the inward current and the conductancecGMP. In some patch-cram experiments, the recipient
cell was not voltage clamped. Therefore, patch conduc- of the detector patch, which resembled the effect of
direct application of cGMP onto the detector patch (Fig-tance rather than absolute current was used as an indi-
cator of cGMP, so that the influence of cellular voltage ure 3B). Since our control experiments suggest that
other intracellular messengers have no effect on thechanges on the detector patch current could be disre-
garded. Changes in conductance upon addition and re- detector patches, it is very likely that the response spe-
cifically results from a change in cytoplasmic cGMP.moval of cGMP occurred rapidly, reaching steady state
within 2 s (see Figure 2C). Figure 3C shows the calculated conductance response
along with the precalibration with cGMP before cram-Figure 3A shows a recording from a detector patch
and a recipient neuroblastoma cell as the patch is in- ming, and postcalibration at the end of the experiment,
after removing the detector patch electrode from theserted into the cell. Immediately before cramming, 1 mM
cGMP was added to the bathing medium. To determine cell. The conductance change elicited by oxo-M reflects
an apparent increase of cGMP from ,1 mM to nearly 5when the detector patch entered the cell, the detector
patch current was monitored. Successful impalement mM. Our data are consistent with resting cGMP concen-
trations in most cells being z1 mM and peak cGMP, inwas accompanied by a precipitous drop in the detector
patch current, indicating a low resting level of cGMP in response to saturating agonist concentrations, reaching
2±10 mM.the cytoplasm. In this example, the current necessary
to hold the recipient cell at 250 mV increased from 100
to 300 pA during insertion of the detector patch but Kinetics of cGMP Responses
We used the patch-cramming method to examine therecovered within 20 s. Typically, the holding current re-
covered within 1 min; cells that did not recover within kinetics of cGMP responses to oxo-M and NO. Oxo-M
is proposed to elevate cGMP levels through a series of2 min were not used. In the 15% of experiments in which
the recipient cell was not voltage clamped, detector events, beginning with activation of muscarinic recep-
tors on the plasma membrane and involving Ca21 activa-patch responses appeared identical to responses in
voltage-clamped cells. In all patch-cramming experi- tion of NOS, production of NO, and activation of soluble
guanylate cyclase (Hu and el-Fakahany, 1993; Mathesments, only cells with a diameter of .40 mm were used,
since smaller cells were unable to survive impalement and Thompson, 1996). In contrast, NO can diffuse into
the cell and directly activate soluble guanylate cyclase.with a patch electrode (tip diameter, 1±2 mm). With cell
diameters of .60 mm, the detector patch remained in- Muscarinic activation of guanylate cyclase involves
more steps than activation triggered by NO, suggestingtact and the recipient cell survived impalement z40%
of the time. that muscarinic cGMP responses might have a longer
delay and a slower rise than NO responses. However,Application of the muscarinic agonist oxotremorine-M
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Figure 3. cGMP Detection during a Patch-
Cramming Experiment
(A) Recording of current from a recipient cell
(top) and a detector patch (bottom) during
the moment of patch cramming. The holding
current of the recipient cell increased from
an initial value of 2100 to 2300 pA during the
ªcramº and then recovered. Detector patch
currents in response to 75 mV pulses, which
initially reflect 1 mM cGMP in the bath, drop
as the patch enters the cytoplasm.
(B) Changes in patch current in response to
a muscarinic agonist (10 mM oxo-M) applied
for 1 min. Currents were elicited with pulses
as shown in Figure 2C.
(C) Conductance values calculated from the
current record in (B). For this and all subse-
quent figures, the gray triangles on the left
ordinate represent cGMP calibrations before
cramming (precalibration), whereas those on
the right represent cGMP calibrations after
withdrawal from the recipient cell (postcali-
bration). Agonist was applied for the time in-
dicated by the dark bar.
cGMP responses elicited with either NOR-4 (an NO do- elicited by oxo-M (8.22 6 0.44 s, n 5 8; see Figure 4B).
The longer delay of the oxo-M response may indeed benor) or oxo-M have a similar rate of rise (Figure 4A),
suggesting that the same rate-limiting step regulates due to the multiple upstream events leading to activation
of guanylate cyclase.cGMP production. NO acts directly on guanylate cy-
clase; therefore, cGMP synthesis is likely to be rate To confirm the involvement of NOS and soluble gua-
nylate cyclase in the elevation of cGMP, we examinedlimiting. The rapid response of detector patches to per-
fusion of cGMP (Figure 2C) or photolysis of caged cGMP oxo-M and NO responses after preincubation of neuro-
blastoma cells with specific, membrane-permeant inhib-(,300 ms; unpublished data) suggests that cGMP de-
tection itself is not rate limiting. itors of each enzyme. Figure 5A shows that the oxo-M
response was eliminated by ODQ, an inhibitor of guanyl-Despite the similar rate of rise, responses to oxo-M
and NO have a different falling phase. Responses to NO ate cyclase, and almost completely blocked by 7-nitroin-
dazole (7-NI), an inhibitor of NOS (Moore et al., 1993;often return to a baseline level of cGMP that is slightly
higher than before NO application, perhaps indicating Silva et al., 1993). In contrast, the NOR-4 response was
blocked by ODQ but was unaffected by 7-NI (Figure 5B).some accumulation of basal cGMP. In contrast, oxo-M
responses often have a marked undershoot, resulting These results are consistent with the notion that the
muscarinic response involves production of NO by NOSin a significantly lower baseline level of cGMP. This de-
crease in basal cGMP must result from a change in the leading to activation of guanylate cyclase, whereas the
NOR-4 response results from direct activation of guanyl-equilibrium of resting cGMP production and degradation
after muscarinic activation. Incubating the cells for 10 ate cyclase by NO.
min with 10 mM ODQ (1H-[1,2,4]oxadiazolo[4,3-a]qui-
noxalin-1-one), a specific inhibitor of soluble guanylate Plasticity of cGMP Responses
G protein±coupled receptors, such as muscarinic AChcyclase (Garthwaite et al., 1995), reduced basal cGMP
to undetectable levels, confirming that there is a high receptors, often exhibit desensitization after prolonged
activation (Grady et al., 1997). Mechanisms contributinglevel of cGMP synthesis at rest. The latency of the cGMP
response after NO application was 5.13 6 0.29 s (n 5 to receptor desensitization include phosphorylation by
receptor kinases (e.g., bARK or protein kinase C; Haga8), which was significantly shorter than the response
Monitoring cGMP in Living Neurons
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Figure 5. Role of NOS and Guanylate Cyclase in cGMP Responses
Peak cGMP responses to 10 mM oxo-M (A) and 100 mM NOR-4 (B)
in control cells (n 5 10) and cells preincubated with 5 mM 7-NI (5
min, n 5 3) or 10 mM ODQ (10 min, n 5 4).
min (n 5 3). This apparent desensitization was superim-
Figure 4. Kinetics of cGMP Responses posed on the cGMP undershoot, which brought basal
(A) Average cGMP response to NOR-4 or oxo-M from different cells cGMP levels down to below 0.5 mM.
(n 5 5). Only the first cGMP response to oxo-M from patch-cramming
In contrast to oxo-M responses, direct activation ofexperiments was used. The dark bar indicates the time of agonist
soluble guanylate cyclase with NO resulted in responsesapplication. The error bars represent the SEM for the five oxo-M or
that did not desensitize with either repeated or continu-NOR-4 responses.
(B) Same traces as in (A) at a higher time resolution showing the ous applications of NOR-4 (Figures 6C and 6D). The
shorter delay of the NOR-4 cGMP response. The dashed line indi- ability of NO to repeatedly elevate cGMP suggests that
cates the initiation of agonist application and the arrows indicate the decline of muscarinic responsiveness does not in-
onset of the cGMP response (conductance, .300 pS over baseline).
volve an inability to produce cGMP because of depletion
of cytoplasmic GTP. It also suggests that there is no
feedback inhibition of guanylate cyclase by cGMP.
et al., 1993) and receptor internalization (Liles et al., Surprisingly, muscarinic activation not only inhibited
1986). However, changes in the magnitude of muscarinic subsequent responses to oxo-M, it also suppressed the
responses might also result from downstream changes cGMP response to NO. Figure 7 shows that NOR-4 appli-
in the signaling cascade. Muscarinic elevation of cGMP cations that followed oxo-M responses were completely
in sympathetic neurons and neuroblastoma cells has unable to elevate cGMP. This long-term suppression
been reported to decrease with repeated or continuous (LTS) of cGMP persists for .30 min and occurred in
stimulation (Cioffi and el-Fakahany, 1989; Hu and el- every cell tested (n 5 14). To rule out the possibility that
Fakahany, 1993; Ando et al., 1994). Our evidence sug- LTS of cGMP is caused by a change in sensitivity of the
gests that the decrement of cGMP responses is primarily CNG channels in the detector patch, in most experi-
due to downstream events that are independent of re- ments, the patch was recalibrated at the end of the
ceptor desensitization. experiment after removing it from the cell. In addition,
We examined the cGMP response to prolonged or applications of 8-pCPT±cGMP (8-para-chlorothio-cGMP),
repeated muscarinic activation using the patch-cram a nonhydrolyzable membrane-permeant analog of cGMP,
technique. During prolonged applications of oxo-M (3 produced consistent, repeatable responses while the
min), the cGMP level first rose at least 5-fold and then patch was within the cell, even after LTS, confirming
rapidly declined to below baseline levels, even in the that the sensitivity of the biosensor did not change (data
continued presence of agonist (Figure 6A). Repeated 1 not shown).
min oxo-M applications triggered cGMP transients that We have further considered the possibility that the
declined progressively, such that by the third applica- decrement of cGMP responses following muscarinic ac-
tion, there was no rise in cGMP (Figure 6B). The loss of tivation results from a reduction in the pool of cyto-
oxo-M responsiveness was sustained, such that cGMP plasmic GTP available as a substrate for cGMP synthe-
sis. To further test this possibility, we applied isobutylelevations were completely eliminated for at least 15
Neuron
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Figure 6. Muscarinic cGMP Responses Desensitize, Whereas NO Responses Do Not
Detector patch response to 10 mM oxo-M (A) or 100 mM NOR-4 (C) applied for 3 min. Three consecutive responses to oxo-M (B) or NOR-4
(D) applied for 1 min.
methylxanthine (IBMX), an inhibitor of PDE. IBMX alone have already shown that the rising phase of the cGMP
response is rate limited by guanylate cyclase. Figure 8Bproduced a large rise in cGMP, which persisted after
application of oxo-M, unlike the response to NOR-4 (Fig- shows that the rising phase of the cGMP response to
IBMX is nearly identical before and after induction ofure 8A). The persistence of the IBMX response indicates
that oxo-M does not deplete cytoplasmic GTP. The ob- LTS, suggesting that basal guanylate cyclase activity is
unchanged during LTS.servation that IBMX alone elicits an increase in cyto-
plasmic cGMP in neuroblastoma cells supports the no- Figure 9 summarizes results from many experiments
in which the same agonist (e.g., NO or oxo-M) was ap-tion that both guanylate cyclase and PDE have relatively
high basal activities. If LTS is associated with a decrease plied three times in succession or in which different
agonists were alternated. Responses to repeated appli-in guanylate cyclase activity, the rate of cGMP produc-
tion should decrease after the induction of LTS. We cations of NO did not decrease, unlike responses to
Figure 7. Muscarinic Activation Causes LTS of the cGMP Response to NO
cGMP responses during 1 min applications of 50 mM NOR-4 before and after applying 10 mM oxo-M. Note the suppression of cGMP responses
following oxo-M application.
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To determine if LTS occurs in sympathetic neurons,
we used an enzyme-immunoassay to measure total
cGMP in rat superior cervical ganglion cells. These re-
sults were compared with similar measurements from
neuroblastoma cells. The cGMP response to oxo-M in
sympathetic neurons was reduced by 82% 6 14% (n 5
3) by preincubation with 7-NI, suggesting that sympa-
thetic neurons and neuroblastoma cells both utilize a
common biochemical cascade involving NOS for medi-
ating muscarinic production of cGMP, consistent with
previous studies (Sheng et al., 1993; Ando et al., 1994).
To investigate LTS, agonists (oxo-M and NOR-4) were
applied in the same sequences as in patch-cramming
experiments, and cells were collected before and during
each agonist treatment. When NO was applied repeat-
edly, each NO application generated consistent in-
creases in cGMP in both neuroblastoma cells (Figure
10A) and sympathetic neurons (Figure 10C). However,
when oxo-M was used, the muscarinic agonist sup-
pressed the subsequent NO-induced increase in cGMP,
in both cell types (Figures 10B and 10D). Hence, these
results parallel those of patch-cramming experiments
and demonstrate that the suppression of cGMP produc-
tion is not limited to neuroblastoma cells but may be a
general property of other mammalian neurons.
Additional biochemical experiments were performed
Figure 8. cGMP Responses to IBMX Do Not Exhibit LTS to determine if LTS reverses after prolonged recovery
periods, by extending the time between the second and(A) Responses to 100 mM IBMX and 100 mM NOR-4 before and 2
min after application of 10 mM oxo-M. Note that the response to third agonist applications (Figure 10E). At 15 and 30 min
NOR-4 is suppressed, whereas the response to IBMX is not. Vertical after oxo-M application, LTS showed little recovery at
scale, 4 nS (IBMX) and 2 nS (NOR-4). Horizontal scale, 1.25 min room temperature (228C). After a 2 hr recovery time at
(IBMX) and 0.75 min (NOR-4). 378C, the average cGMP response of oxo-M-treated
(B) Rising phase of cGMP response to IBMX before and after oxo-M
cells was still lower than controls, but the differenceapplication.
was not statistically significant (p 5 0.28, paired t test).
Thus, LTS does slowly recover but requires more than
repeated oxo-M. NO had no effect on oxo-M responses, 30 min and possibly hours to recover from a 2 min appli-
whereas oxo-M nearly completely eliminated cGMP re- cation of muscarinic agonist.
sponses to NO. LTS was dramatic and persistent; at 2
and 30 min after oxo-M application, the ability of NO to Discussion
elevate cGMP was suppressed by 97.7% 6 1.5% and
99.4% 6 1.2%, respectively. Other muscarinic agonists Application of the Patch-Cramming Method
(muscarine, carbachol, and ACh) also produced LTS. to Detection of cGMP
However, the response to IBMX was only slightly re- Patch cramming utilizes ion channels gated by a given
intracellular ligand for monitoring levels of that ligandduced by application of oxo-M.
Figure 9. Summary of Patch-Cramming Results Demonstrating LTS of cGMP Responses to NOR-4 by Oxo-M but Not Vice Versa and Showing
that IBMX Responses Persist
Each bar represents the cGMP concentration attained during the third treatment period normalized to the first. cGMP concentration was
calculated from the Hill fit to cGMP precalibrations for each experiment. The sequence of application of agonists during each experiment is
given at the bottom of each bar, with 2±3 min intervals between treatments except for the indicated experiment in which there was a 30 min
interval between the second and third agonist applications. N4, NOR-4; OX, oxo-M; C, control saline; IB, IBMX.
Neuron
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Figure 10. Biochemical Measurements of LTS
(A±D) Enzyme-immunoassay measurements of cGMP in cultured neuroblastoma (A and B) and rat sympathetic neurons (C and D) also
demonstrate LTS after muscarinic activation. Cells were lysed at times indicated (see timeline) and assayed for total cGMP and protein content
(n 5 4±6). Timelines show the treatment protocol ([A and C] N4/N4/N4, [B and D] N4/OX/N4).
(E) The timecourse of recovery from LTS. Each bar represents the level of cGMP in response to the third and final agonist application (n 5
4). In the N4/N4/N4 experiments, there was no significant suppression of cGMP during the third application, whereas with N4/OX/N4, cGMP
was significantly suppressed for at least 30 min. Indicated times represent intervals between the end of the second agonist application (shown
in the timelines by the asterisk) and the beginning of the third.
in an intact heterologous cell (Kramer, 1990). In this mm. Cells large enough for patch cramming may include
sympathetic and parasympathetic neurons, dorsal rootstudy, cGMP-selective electrodes were manufactured
using CNG channels as biosensors, providing the first ganglion neurons, retinal horizontal cells, and possibly
cerebellar Purkinje neurons. Appropriate nonneuronalmeasurements of cGMP in a living cell. Alternate meth-
ods for monitoring cGMP have not been described. Even cell types include skeletal or cardiac myocytes and oo-
cytes.if a cGMP-sensitive indicator comparable to FlCRhR
were developed, in certain respects the patch-cram
method would have advantages over such optical meth- LTS of cGMP and Its Possible
Underlying Mechanismsods. The detector patch electrode is easy to calibrate,
both before and after an experiment, and responds to The continuous monitoring of cGMP, made possible
with the patch-cramming technique, has revealed a re-cGMP rapidly and consistently. Unlike FlCRhR, the de-
tector patch will not significantly alter or buffer the level markable new phenomenon in which muscarinic activa-
tion triggers LTS of subsequent cGMP responses. Re-of cyclic nucleotides in cells. Moreover, the kinetics and
spatial resolution of the FlCRhR method are confounded peated or prolonged activation of G protein±coupled
receptors induces homologous receptor desensitiza-by compartmentalization and mixing of the subunits with
native cyclic nucleotide±regulated proteins (Adams et tion. Mechanisms contributing to this process include
phosphorylation and internalization of the receptor pro-al., 1991), problems that will not occur with patch cram-
ming. One disadvantage is that the detector patch moni- teins. We feel that these processes cannot underlie the
LTS of cGMP described here. The M1 receptor is re-tors cGMP at a single site within a cell, whereas optical
imaging with indicator dyes can provide information sponsible for muscarinic modulation of ionic currents
(e.g., M current; Hamilton et al., 1997) and can regulateabout spatial distribution. Also, patch cramming utilizes
a relatively large pipette, requiring the use of a suffi- cGMP (Mathes et al., 1992) in neurons. Binding studies
show that desensitization of the M1 receptor, involvingciently large recipient cell. So far, the lower limit of cell
diameter for successful patch cramming has been z40 phosphorylation by protein kinase C (Lai et al., 1990)
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and internalization (Liles et al., 1986), occurs with a t1/2 detector patch sensitivity to cGMP (Figure 2). For these
reasons, we are confident that the detector patch isof z5 min (Cioffi and el-Fakahany, 1989), much more
slowly than LTS of cGMP, which requires ,1 min of specific for cGMP and is stable during patch-cramming
experiments.agonist application. Furthermore, cGMP suppression is
sustained for up to 2 hr, whereas recovery from homolo-
gous receptor desensitization is complete within 30 min
Functional Significance of cGMP and LTS(Feigenbaum and el-Fakahany, 1985). Moreover, musca-
Identifying specific physiological functions for cGMP inrinic suppression of the M current in sympathetic neu-
neurons has been elusive, in part because methods forrons exhibits little desensitization when agonists are
detecting cGMP have been unavailable. Nonetheless, itapplied for periods as long as 10 min (Adams et al.,
is likely that cGMP is important both for directly mediat-1982). Finally, LTS applies not only to muscarinic eleva-
ing synaptic events and contributing to plasticity. Intion of cGMP but also to elevation induced by NO. Thus,
sympathetic ganglia, cGMP may mediate part of thethe events underlying LTS must occur downstream from
slow depolarization elicited by muscarinic agoniststhe receptor.
(Hashiguchi et al., 1982; Kobayashi et al., 1992). In addi-NO directly activates guanylate cyclase. Therefore,
tion, NO and cGMP can potentiate nicotinic synapticLTS of responses to NO and probably to muscarinic
transmission (Briggs, 1992; Southam et al., 1996). Sinceagonists are not due to changes in G protein signaling
muscarinic activation induces LTS, we would predictor Ca21 mobilization but rather must be due to downreg-
that ACh release that is sufficiently intense and pro-ulation of guanylate cyclase, upregulation of PDE, or
longed to activate muscarinic receptors should induceboth. The observations that IBMX responses persist
LTS and prevent NO-induced potentiation. Whereasafter LTS and that the rise time of cGMP does not change
some previous studies have failed to detect significantsuggest that LTS is not associated with a decrease in
NOS activity in rat postganglionic sympathetic neuronsbasal guanylate cyclase activity. However, it is possible
(Anderson et al., 1993; Dun et al., 1993; Schmidt et al.,that the ability of NO to activate guanylate cyclase is
1993b), our results utilizing the specific NOS inhibitorreduced during LTS, and this could account for the in-
7-NI indicate that muscarinic elevation of cGMP requiresability of NO to elevate cGMP. Finally, it is possible
NOS activity in cultured neonatal postganglionic cells,that mechanisms for inactivating or scavenging NO are
as it does in neuroblastoma cells.persistently upregulated by muscarinic activation, po-
Muscarinic regulation of M current and voltage-gatedtentially contributing to LTS.
Ca21 current is unlikely to involve cGMP (Mathie et al.,The persistence of LTS for up to 2 hr suggests that the
1992; Caulfield et al., 1994). However, cGMP does acti-underlying mechanism involves a covalent modification
vate a nonselective cation current that may play a role(e.g., phosphorylation) of guanylate cyclase, PDE, or
in refilling of intracellular Ca21 stores after IP3-mediatedboth. Since muscarinic activation leads to a Ca21 tran-
Ca21 release (Mathes and Thompson, 1994, 1996; Thomp-sient that does not outlast agonist presence by more
son, 1997). Indeed, changes in cGMP detected with thethan 30 s (Mathes and Thompson, 1996), it is unlikely
patch-cram method have a rise time similar to this cur-that Ca21/calmodulin is responsible for maintenance of
rent (Mathes and Thompson, 1996), but it is not knownLTS. However, it is possible that Ca21 is involved in
whether it too exhibits LTS after prolonged or repeatedinduction of LTS, perhaps by triggering Ca21-dependent
muscarinic activation.phosphorylation.
Muscarinic receptors are not the only ones in theseLTS is not an artifact resulting from a change in the
cells that trigger a rise in cGMP. Bradykinin, ATP, angio-cGMP sensitivity of the detector patch. The consistent
tensin, and neurotensin activate distinct G protein±calibration responses seen before and after patch cram-
coupled receptors leading to cGMP elevation throughming (see Figures 3, 6, and 7) demonstrate that the CNG
a common signaling cascade as that used by muscarinicchannels were not modified in any persistent manner
receptors. Activation of nicotinic ACh receptors andby exposure to the cytoplasm of the recipient cell. In
voltage-gated Ca21 channels also reportedly elevateaddition, application of a subsaturating concentration
cGMP (Study et al., 1978). It will be interesting to exam-of pCPT±cGMP (0.2 mM) elicits the same conductance
ine the kinetics of cGMP transients in response to theseresponse before patch cramming and after insertion into
stimuli and to investigate whether these responses arethe recipient cell, even after induction of LTS (data not
also suppressed after induction of LTS.shown), demonstrating that the detector patch sensitiv-
Our kinetic experiments show that guanylate cyclaseity is not altered in a transient manner by the cytoplasmic
produces cGMP at a slow rate in response to activationmilieu. The detector patch membrane contains a very
by NO. The observation that IBMX alone elevates cGMPhigh density of RONS2 channels. The only other chan-
(Figure 8 and Graeff et al., 1987) suggests that there isnels intrinsic to Xenopus oocytes that might conceivably
a constant turnover of cGMP owing to robust guanylatecontribute to the conductance of the detector patch are
cyclase and PDE activities. Activation of muscarinic re-Ca21-activated Cl2 channels. We find that these chan-
ceptors leads to a rise in cGMP followed by a reductionnels are present at a relatively low density (,5 channels
in the resting level, shifting the equilibrium between syn-per patch) compared to the RONS2 channels (.800 per
thesis and degradation. The resting level of cGMP be-patch). Moreover, with 20 mM Cl2 in the pipette, the
fore LTS is sufficiently high (z1 mM) to nearly saturatedriving force for Cl2 is minimal, such that direct applica-
activation of cGMP-dependent protein kinase (PKG),tion of Ca21 to the detector patch elicits undetectable
which has a Kd of 110 nM (Francis and Corbin, 1994).current. In addition, Ca21/calmodulin, NO, and cAMP (at
,100 mM) do not directly activate RONS2 or affect the LTS may lower the basal concentration of cGMP to a
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mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM Na-HEPES, and 10 mMrange that allows dynamic regulation of PKG activity. In
D-glucose (pH adjusted to 7.4 with NaOH). An excised, inside-outcontrast to PKG, CNG channels are much less sensitive
patch (the cGMP detector patch) was obtained from the oocyte andto cGMP and might become completely inactive during
calibrated with 4±5 cGMP concentrations ranging from 0.5 to 100
LTS. Hence, LTS could provide a mechanism for select- mM. Next, with a second patch electrode connected to a second
ing which effector is dynamically regulated by changes patch-clamp amplifier (Warner Instruments PC-501A), a nystatin
perforated patch was obtained on a neuroblastoma cell for whole-in cGMP.
cell recording (Horn and Marty, 1988). Perforated patch pipettescGMP may be a mediator of long-term synaptic plas-
were back-filled with a solution containing 90 mM K2SO4, 20 mMticity in the CNS. In the CA1 region of the hippocampus,
KCl, 1.5 mM MgCl2, 5 mM Na-HEPES, and 100±200 mg/ml nystatinone proposed mechanism for LTP involves NO, which
(pH adjusted to 7.4 with NaOH), while the tip was filled with the
may act as a retrograde signal that enhances neuro- same solution devoid of nystatin.
transmitter release from presynaptic terminals (Schu- After access resistance declined to ,60 MV, the membrane po-
tential was held under voltage clamp (250 mV), and the neuro-man and Madison, 1991). Recent studies suggest that
blastoma cell was impaled with the detector patch electrode. Suc-cGMP mediates this effect of NO. Exogenous cGMP
cessful impalement was confirmed by the appearance of an offsetenhances transmitter release from cultured hippocam-
in the oocyte patch current due to the potential difference acrosspal neurons (Arancio et al., 1995), whereas inhibition of
the neuroblastoma cell membrane. During the calibration, the oocyte
either soluble guanylate cyclase (Zhuo et al., 1994) or patch was held at 275 mV, and 350 ms duration voltage pulses to
PKG (R. D. Hawkins, personal communication) blocks 0 mV were applied at 2 Hz. Currents resulting from these pulses
were measured to calculate conductance changes in response toinduction of LTP. Finally, in cerebellar Purkinje neurons,
cGMP. After insertion into the recipient cell, the detector patch wasproduction of NO and cGMP is necessary (Shibuki and
held at 225 mV, so the total voltage difference across the detectorOkada, 1991) and, in conjunction with Ca21, sufficient
patch was the same as during the calibration (275 mV). Changes(Lev-Ram et al., 1997) for inducing LTD of synaptic trans-
in intracellular cGMP were recorded as changes in detector patch
mission. Purkinje cells are richly endowed with NOS, conductance. Solutions were continuously superfused over the neu-
soluble guanylate cyclase, and PKG and have a high roblastoma cell. All pharmacological agents, including cGMP, nys-
tatin, IBMX (Sigma), 7-NI, NOR-4 (Calbiochem), oxo-M (RBI), pCPT±density of muscarinic receptors (Ross et al., 1990; Lin-
cGMP (Biolog), and ODQ (Tocris) were prepared as concentratedden and Connor, 1993). Thus, they may contain all of
stock solutions in water or DMSO, and aqueous solutions containingthe necessary components for LTS. It will be interesting
the final concentrations were prepared for use as needed. The finalto determine if activation of muscarinic or other recep-
concentration of DMSO did not exceed 0.1% and had no effect on
tors that utilize a similar signaling cascade influence the cGMP detector patch. The NO donor NOR-4 was used in all
LTD in Purkinje cells by inducing LTS of cGMP. patch-cramming experiments because of its long half-life (60 min),
which ensures that short (1±3 min) applications approximate step
changes in NO concentration and allows its use during prolongedExperimental Procedures
experiments (15 min) necessary for studying LTS. When individual
applications of NOR-4 were used .20 min apart on the same cells,Expression and Recording from Oocyte CNG Channels
a new batch of NOR-4 solution was prepared and loaded into theA cDNA clone encoding a chimeric CNG channel, RONS2 (Goulding
perfusion apparatus.et al., 1994), was used for in vitro transcription of cRNA, as described
previously (Goulding et al., 1992). The cRNA was injected into Xeno-
pus oocytes at high concentrations (50 nl/oocyte at 0.2±0.3 ng/nl)
Sympathetic Neuron Culturesto obtain high levels of expression. After 2±7 days, the vitelline
Superior cervical ganglia were dissected from 1±3 day postnatalmembrane was removed from injected oocytes, and the denuded
rats, desheathed, incubated in collagenase (1 mg/ml, 15 min), tritu-oocytes were carefully placed in the experimental chamber. Glass
rated, and plated onto poly-L-lysine-coated plastic culture dishespatch pipettes (2±4 MV) were filled with a solution containing 100
at approximately one ganglion per dish. Cells were maintained inmM potassium gluconate, 20 mM KCl, and 10 mM Na-HEPES (pH
DMEM with 10% horse serum, 1% pen/strep, 0.5 mM glutamine,adjusted to 7.4 with NaOH). This also served as the standard cGMP
and 50 ng/ml nerve growth factor (NGF) (7S). Cultures were kept atcalibration solution. After formation of a gigaohm seal, inside-out
378C in an incubator with 10% CO2. The medium was changed twicepatches were excised and the patch pipette was placed in the outlet
per week and the neurons were allowed to mature for 8±10 days.of a 1 mm diameter tube for application of cGMP at various concen-
trations. We used a perfusion manifold, containing up to 15 different
solutions, that is capable of solution changes within 200 ms. Current
Biochemical Measurements of cGMPresponses through CNG channels were obtained with a Warner PC-
cGMP was assayed in cultured neuroblastoma or sympathetic neu-505 patch clamp (Warner Instrument, Hamden, CT), filtered at 1
rons using the Biotrak enzyme-immunoassay system (AmershamkHz, digitized, stored, and later analyzed on a computer. Membrane
Life Science). Cells were treated with agonist and reactions werepotential was held at 275 mV for all experiments. Variability among
terminated by applying 6% (wt/vol) trichloroacetic acid. Cells weremeasurements is expressed as mean 6 SEM.
scraped into microfuge tubes and centrifuged, and the supernatant
was washed with diethyl ether before determining cGMP. The pellet
Cell Culture was used for assaying total protein content (Biorad Protein Assay
N1E-115 neuroblastoma cells (Amano et al., 1972) were maintained Kit II).
in DMEM with 10% FBS at 378C with 10% CO2. Cells were grown
to 70% confluence on poly-L-lysine-coated glass coverslips before
treating with 2% DMSO for 10±21 days to induce differentiation, Acknowledgments
characterized by the appearance of processes, voltage-gated ionic
currents, and action potentials (Kimhi et al., 1976; Moolenaar and We wish to thank Stuart H. Thompson for helpful advice and partici-
Spector, 1978). Culture medium was exchanged every 2±3 days and pation in preliminary experiments and Michael D. Vendiola for tech-
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The denuded oocyte and a glass coverslip containing differentiated
neuroblastoma cells were placed in the same experimental re-
cording chamber. The bath solution contained 120 mM NaCl, 2.5 Received May 4, 1998; revised August 6, 1998.
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